Inactive Provider
This provider's NPI has been deactivated on 05/07/2026. The information on this page is historical and may no longer be current.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $107,934 | 58 | 91.1% |
| Food and Beverage | $4,975 | 244 | 4.2% |
| Honoraria | $3,000 | 1 | 2.5% |
| Travel and Lodging | $2,089 | 35 | 1.8% |
| Consulting Fee | $450.00 | 3 | 0.4% |
| Education | $54.96 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $58,449 | 200 | $0 (2024) |
| Allergan, Inc. | $41,802 | 76 | $0 (2021) |
| EMD Serono, Inc. | $14,097 | 48 | $0 (2023) |
| Upsher-Smith Laboratories LLC | $3,246 | 2 | $0 (2017) |
| Biogen, Inc. | $365.73 | 6 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $170.68 | 4 | $0 (2022) |
| Alkermes, Inc. | $150.00 | 1 | $0 (2017) |
| Avanir Pharmaceuticals, Inc. | $109.00 | 1 | $0 (2017) |
| Assertio Therapeutics, Inc. | $54.96 | 4 | $0 (2018) |
| Biohaven Pharmaceutical Holding Company Ltd. | $43.81 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,194 | 28 | ABBVIE INC. ($8,194) |
| 2023 | $6,665 | 41 | AbbVie Inc. ($6,487) |
| 2022 | $11,351 | 62 | ABBVIE INC. ($11,194) |
| 2021 | $41,442 | 88 | AbbVie Inc. ($32,574) |
| 2020 | $33,037 | 70 | Allergan, Inc. ($33,007) |
| 2019 | $215.05 | 5 | Biogen, Inc. ($150.00) |
| 2018 | $7,263 | 28 | EMD Serono, Inc. ($7,024) |
| 2017 | $10,336 | 23 | EMD Serono, Inc. ($6,805) |
All Payment Transactions
345 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | ABBVIE INC. | QULIPTA (Drug) | Travel and Lodging | In-kind items and services | $35.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $99.25 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | ABBVIE INC. | UBRELVY (Drug) | Travel and Lodging | In-kind items and services | $20.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $115.33 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 774 | 843 | $326,930 | $88,133 |
| 2022 | 6 | 770 | 890 | $324,802 | $91,323 |
| 2021 | 8 | 812 | 941 | $322,363 | $92,601 |
| 2020 | 7 | 819 | 5,597 | $396,984 | $106,384 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 388 | 457 | $147,611 | $42,924 | 29.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 317 | 317 | $160,257 | $38,611 | 24.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 31 | 31 | $7,750 | $2,927 | 37.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 18 | $7,812 | $2,258 | 28.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 20 | 20 | $3,500 | $1,413 | 40.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 407 | 488 | $157,624 | $46,633 | 29.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 293 | 293 | $148,051 | $38,584 | 26.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 30 | $13,020 | $4,676 | 35.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 15 | 17 | $2,975 | $1,006 | 33.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 33 | $2,904 | $385.00 | 13.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 12 | 29 | $228.00 | $38.24 | 16.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 319 | 319 | $161,095 | $43,137 | 26.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 361 | 412 | $133,076 | $41,451 | 31.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 43 | 47 | $8,225 | $2,866 | 34.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 30 | 31 | $7,750 | $2,795 | 36.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $4,644 | $863.25 | 18.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 11 | $2,409 | $790.08 | 32.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 18 | 55 | $4,840 | $618.63 | 12.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 18 | 54 | $324.00 | $80.30 | 24.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 238 | 238 | $120,448 | $30,690 | 25.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 318 | 372 | $120,156 | $28,209 | 23.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 12 | 4,700 | $70,500 | $22,785 | 32.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 208 | 229 | $57,250 | $19,485 | 34.0% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2020 | 12 | 24 | $21,888 | $3,049 | 13.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 18 | $3,942 | $1,119 | 28.4% |
About Dr. Alan Shepard, MD
Dr. Alan Shepard, MD is a Neurology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245223767.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Shepard, MD has received a total of $118,503 in payments from pharmaceutical and medical device companies, with $8,194 received in 2024. These payments were reported across 345 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($107,934).
As a Medicare-enrolled provider, Shepard has provided services to 3,175 Medicare beneficiaries, totaling 8,271 services with total Medicare billing of $378,441. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Chicago, IL
- Active Since 08/30/2005
- Last Updated 01/18/2026
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1245223767
Products in Payments
- UBRELVY (Drug) $85,523
- Rebif (Biological) $13,849
- QULIPTA (Drug) $11,587
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $3,246
- BOTOX (Biological) $3,141
- TYSABRI (Biological) $365.73
- AJOVY (Drug) $143.53
- NUEDEXTA (Drug) $109.00
- NURTEC ODT (Drug) $59.58
- Cambia (Drug) $54.96
- Mavenclad (Biological) $45.35
- AJOVY (Biological) $27.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Chicago
Mr. Augusto Miravalle, Md, MD
Neurology — Payments: $1.1M
Adil Javed
Neurology — Payments: $1.0M
Douglas Nordli, Md, MD
Neurology — Payments: $654,190
Dr. Dusan Stefoski, Md, MD
Neurology — Payments: $610,165
Dr. Danny Bega, M.d, M.D
Neurology — Payments: $432,383
Tatyana Simuni, Md, MD
Neurology — Payments: $385,696